Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meteospasmyl in Irritable Bowel Syndrome
NCT00542295Phase 4Completed
- Sponsor
- Mayoly Spindler
- Start
- Jul 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of alverine citrate + simeticone in irritable bowel syndrome (IBS), sponsored by Mayoly Spindler. Started Jul 2007; status: completed.
02
Drugs
alverine citrate + simeticone
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00542295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542295.